Annual report
4465.TEDINET S100U9V7
Period2023-06-01 → 2024-05-31
Filed2024-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.7bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥19.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥17.8bn | 2021-06-01 → 2022-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.4bn | 2020-06-01 → 2021-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.7bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.5bn | 2023-06-01 → 2024-05-31 | Cons. | Operating income |
| Operating income | ¥855m | 2022-06-01 → 2023-05-31 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.9bn | 2021-06-01 → 2022-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2020-06-01 → 2021-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥812m | 2023-06-01 → 2024-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥899m | 2022-06-01 → 2023-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥706m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.2bn | 2021-06-01 → 2022-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥697m | 2020-06-01 → 2021-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥716m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss |
| Net income | ¥562m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss |
| Total assets | ¥22.7bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥20.8bn | at 2022-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.5bn | at 2021-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.8bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.4bn | at 2024-05-31 | Cons. | Liabilities |
| Total liabilities | ¥10.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.4bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.5bn | at 2022-05-31d | Cons. | Net assets |
| Net assets / equity | ¥11.3bn | at 2021-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥10.6bn | at 2020-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.0bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.8bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2021-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.3bn | at 2020-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.3bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2021-06-01 → 2022-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥102m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥690m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥616m | 2021-06-01 → 2022-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥935m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.4bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥92m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥789m | 2021-06-01 → 2022-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.7bn | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥464m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥119.58 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.59 | 2021-06-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥118.11 | 2020-06-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥179.32 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,267.35 | at 2024-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,179.33 | at 2023-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,121.49 | at 2022-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,912.9 | at 2021-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,788.74 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 58.9% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2022-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.2% | at 2021-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.4% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.4% | 2023-06-01 → 2024-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.4% | 2022-06-01 → 2023-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2021-06-01 → 2022-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2020-06-01 → 2021-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 394 | at 2024-05-31 | Cons. | Number of employees |
| Employees | 394 | at 2023-05-31 | Cons. | Number of employees |
| Employees | 339 | at 2022-05-31d | Cons. | Number of employees |
| Employees | 344 | at 2021-05-31d | Cons. | Number of employees |
| Employees | 358 | at 2020-05-31d | Cons. | Number of employees |
| Revenue | ¥19.1bn | 2023-06-01 → 2024-05-31 | Standalone | Net sales |
| Revenue | ¥18.4bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales |
| Revenue | ¥16.9bn | 2021-06-01 → 2022-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.0bn | 2020-06-01 → 2021-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.5bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2023-06-01 → 2024-05-31 | Standalone | Operating income |
| Operating income | ¥997m | 2022-06-01 → 2023-05-31 | Standalone | Operating income |
| Ordinary income | ¥1.2bn | 2023-06-01 → 2024-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.8bn | 2021-06-01 → 2022-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2020-06-01 → 2021-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥754m | 2023-06-01 → 2024-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.0bn | 2022-06-01 → 2023-05-31 | Standalone | Income before income taxes |
| Net income | ¥788m | 2023-06-01 → 2024-05-31 | Standalone | Profit loss |
| Net income | ¥715m | 2022-06-01 → 2023-05-31 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2021-06-01 → 2022-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥716m | 2020-06-01 → 2021-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥902m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥20.7bn | at 2024-05-31 | Standalone | Assets |
| Total assets | ¥20.6bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥19.6bn | at 2022-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥19.3bn | at 2021-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.9bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.9bn | at 2024-05-31 | Standalone | Liabilities |
| Total liabilities | ¥8.4bn | at 2023-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥12.7bn | at 2024-05-31 | Standalone | Net assets |
| Net assets / equity | ¥12.2bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥11.7bn | at 2022-05-31d | Standalone | Net assets |
| Net assets / equity | ¥10.7bn | at 2021-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥10.1bn | at 2020-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.2bn | at 2024-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥133.46 | 2023-06-01 → 2024-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.18 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥198.41 | 2021-06-01 → 2022-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.28 | 2020-06-01 → 2021-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.8 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥44 | 2023-06-01 → 2024-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥64 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2021-06-01 → 2022-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥26 | 2020-06-01 → 2021-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥26 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,154.42 | at 2024-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,066.02 | at 2023-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,986.14 | at 2022-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,820.18 | at 2021-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,717.54 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 61.5% | at 2024-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.2% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.0% | at 2022-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.6% | at 2021-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.8% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.3% | 2023-06-01 → 2024-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2022-06-01 → 2023-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-06-01 → 2022-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2020-06-01 → 2021-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.2% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,943,000 | at 2024-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2022-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2021-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 239 | at 2024-05-31 | Standalone | Number of employees |
| Employees | 239 | at 2023-05-31 | Standalone | Number of employees |
| Employees | 231 | at 2022-05-31d | Standalone | Number of employees |
| Employees | 234 | at 2021-05-31d | Standalone | Number of employees |
| Employees | 240 | at 2020-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 33
| Segment | Item | Period | Value |
|---|---|---|---|
| Chemical Businessreportable segment | capex | 2023-06-01 → 2024-05-31 | ¥175m |
| Chemical Businessreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥509m |
| Chemical Businessreportable segment | employees | at 2024-05-31 | 371 pure |
| Chemical Businessreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥21.3bn |
| Chemical Businessreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥21.3bn |
| Chemical Businessreportable segment | segment assets | at 2024-05-31 | ¥21.1bn |
| Chemical Businessreportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥1.2bn |
| Healthcare Businessreportable segment | capex | 2023-06-01 → 2024-05-31 | ¥4m |
| Healthcare Businessreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥39m |
| Healthcare Businessreportable segment | employees | at 2024-05-31 | 23 pure |
| Healthcare Businessreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | segment assets | at 2024-05-31 | ¥1.7bn |
| Healthcare Businessreportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥245m |
| —segment total | capex | 2023-06-01 → 2024-05-31 | ¥179m |
| —segment total | depreciation | 2023-06-01 → 2024-05-31 | ¥549m |
| —segment total | revenue | 2023-06-01 → 2024-05-31 | ¥22.7bn |
| —segment total | revenue external | 2023-06-01 → 2024-05-31 | ¥22.7bn |
| —segment total | segment assets | at 2024-05-31 | ¥22.7bn |
| —segment total | segment profit | 2023-06-01 → 2024-05-31 | ¥1.5bn |
| Chemical Businessreportable segment | capex | 2022-06-01 → 2023-05-31 | ¥201m |
| Chemical Businessreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥573m |
| Chemical Businessreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥19.5bn |
| Chemical Businessreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥19.5bn |
| Chemical Businessreportable segment | segment assets | at 2023-05-31 | ¥20.9bn |
| Chemical Businessreportable segment | segment profit | 2022-06-01 → 2023-05-31 | ¥855m |
| Healthcare Businessreportable segment | segment assets | at 2023-05-31 | ¥2.6bn |
| —segment total | capex | 2022-06-01 → 2023-05-31 | ¥201m |
| —segment total | depreciation | 2022-06-01 → 2023-05-31 | ¥573m |
| —segment total | revenue | 2022-06-01 → 2023-05-31 | ¥19.5bn |
| —segment total | revenue external | 2022-06-01 → 2023-05-31 | ¥19.5bn |
| —segment total | segment assets | at 2023-05-31 | ¥23.6bn |
| —segment total | segment profit | 2022-06-01 → 2023-05-31 | ¥855m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,572
| Item | Context | Value | Unit |
|---|---|---|---|
| Redemption of bonds fin cf | CurrentYearDuration | -10000000 | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | Prior1YearDuration | － | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | CurrentYearDuration | -96029000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -271558000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -318785000 | JPY |
| Repayments of lease obligations fin cf | Prior1YearDuration | -3947000 | JPY |
| Repayments of lease obligations fin cf | CurrentYearDuration | -4062000 | JPY |
| Other net fin cf | Prior1YearDuration | -47000 | JPY |
| Other net fin cf | CurrentYearDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -91803000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -1373049000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | 9989000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 60157000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 308312000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 87420000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 6057120000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 6745342000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YearDuration | 379909000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYearDuration | － | JPY |
| Cash and cash equivalents | Prior1YearInstant | 6745342000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 6832763000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 11 | |
| Notes receivable trade | Prior1YearInstant | 475925000 | JPY |
| Notes receivable trade | CurrentYearInstant | 381374000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 2843848000 | JPY |
| Accounts receivable trade | CurrentYearInstant | 3083869000 | JPY |
| Employees salaries and bonuses sga | Prior1YearDuration | 1571647000 | JPY |
| Employees salaries and bonuses sga | CurrentYearDuration | 1697152000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 79895000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 109195000 | JPY |
| Freightage expenses sga | Prior1YearDuration | 1409429000 | JPY |
| Freightage expenses sga | CurrentYearDuration | 1509437000 | JPY |
| Subcontract expenses sga | Prior1YearDuration | 423643000 | JPY |
| Subcontract expenses sga | CurrentYearDuration | 428529000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | -2317000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | 4737000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 270246000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 303318000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00890-000ChemicalBusinessReportableSegmentsMember | 19504189000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 19504189000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 19504189000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00890-000ChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00890-000ChemicalBusinessReportableSegmentsMember | 19504189000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 23 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |